Articles

Builders of Obama’s health website saw red flags

The government spent at least $394 million in contracts to build the federal health care exchange and data hub. The painfully slow and often unresponsive website has frustrated Americans trying to enroll for insurance plans.

Read More

Indiana’s insurance exchanges are pricey

The premiums offered by health insurers participating in the Obamacare exchanges put Indiana among the 10 most-expensive states in the country, according to data released last month by the U.S. Department of Health and Human Services.

Read More

Analysts: Investors wrong to dump Endocyte

Investors on Friday dumped shares of West Lafayette-based Endocyte Inc. after an independent analysis said an experimental lung cancer drug is unlikely to be declared superior to existing chemotherapy. But two analysts say, to the contrary, the analysis shows the prospects for Endocyte’s drug are as good as ever.

Read More

Finding where the money is in health care

More than half of the $2.5 trillion consumers spend annually on health care in the United States flows to hospitals and doctors, with drug companies and health insurers trailing well behind.

Read More

Lilly stock shrugs off analyst downgrade

The drugmaker has become too reliant on its remaining pipeline of drugs under development for growth as it deals with patent expirations to big sellers and drug-development setbacks, a Jefferies analyst wrote.

Read More